Maxx Chatsko

Maxx Chatsko

TMFBlacknGold

Maxx has been a contributor to Fool.com since 2013. He graduated from the State University of New York College of Environmental Science and Forestry (2012) with a Bachelor of Science in Bioprocess Engineering and from Carnegie Mellon University (2016) with a Master of Science in Materials Science & Engineering.

Recent articles





Is Acceleron Pharma a Buy?

The $2 billion development-stage company is about to file for regulatory approval of its lead drug candidate.





3 Top Growth Stocks to Buy Right Now

Investors looking to inject growth into their portfolios should give these companies a closer look.






The 1 Stock I'd Buy Right Now

Most investors have probably never heard of this small-cap laboratory equipment supplier, but it reached an important inflection point in 2018.